Fulvestrant 500 mg Versus Anastrozole 1 mg for the First-Line Treatment of Advanced Breast Cancer: Overall Survival Analysis From the Phase II FIRST Study

Matthew J. Ellis, J.F.R. Robertson, Marek Jasiówka et al.|Journal of Clinical Oncology|2015

Cited by 239